세계의 안과용 점탄성 기기 시장 : 인사이트, 경쟁 구도, 예측(2032년)

Ophthalmic Viscoelastic Devices Market Summary

• The global ophthalmic viscoelastic devices market is expected to increase from USD 459.30 million in 2024 to USD 684.97 million by 2032, reflecting strong and sustained growth.
• The global ophthalmic viscoelastic devices market is growing at a CAGR of 5.21% during the forecast period from 2025 to 2032.
• The market of ophthalmic viscoelastic devices is being primarily driven by the rising prevalence of eye disorders, technological advancements in the product designs, rising awareness and access to eye care, an increase in diabetes prevalence, and an increase in product development activities among the key market players.
• The leading companies operating in the ophthalmic viscoelastic devices market include B. Braun SE, BestMedical, MINZE HEALTH, Santron Medtronic, Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group(R), HCItalia srl, DeltaMed, MEDICA S.P.A., Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd., Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd., and others.
• North America is expected to dominate the overall Ophthalmic Viscoelastic Devices market due to the high prevalence of cataract and glaucoma cases, a rapidly aging population, and strong adoption of advanced ophthalmic surgical procedures. The region benefits from well-established healthcare infrastructure, availability of skilled ophthalmic surgeons, and favorable reimbursement policies. Additionally, the presence of leading market players and continuous product innovations further strengthens North America's dominant position in the global market.
• In the type segment of the ophthalmic viscoelastic devices market, the cohesive ophthalmic viscoelastic category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Ophthalmic Viscoelastic Devices Market

• Rising prevalence of eye disorders leading to a surge in ophthalmic viscoelastic devices: The rising prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy is driving a surge in demand for ophthalmic viscoelastic devices, as these products play a critical role in ensuring safety and precision during eye surgeries. With increasing cases worldwide, especially among the aging population, the need for OVDs is growing significantly to support the rising volume of ophthalmic procedures.
• Rising awareness and access to eye care are escalating the market of ophthalmic viscoelastic devices: Rising awareness about eye health and expanding access to ophthalmic care, particularly in developing regions, are escalating the market for ophthalmic viscoelastic devices. Government initiatives, awareness campaigns, and improved availability of specialized eye hospitals and surgical centers are driving higher adoption of OVDs by enabling more patients to undergo advanced eye surgeries.
• Technological advancement in product design: Technological advancements in product design are boosting the ophthalmic viscoelastic devices market by introducing next-generation OVDs with improved viscosity, stability, and safety profiles. Innovations such as combination cohesive-dispersive formulations and enhanced biocompatibility are enabling better surgical outcomes, increasing surgeon preference, and driving wider adoption in ophthalmic procedures.

Ophthalmic Viscoelastic Devices Market Report Segmentation

This ophthalmic viscoelastic devices market report offers a comprehensive overview of the global Ophthalmic Viscoelastic Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, and Visco-Adaptive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, and Others), End-User (Hospitals, Ophthalmology Clinics, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing ophthalmic viscoelastic devices market.

Ophthalmic viscoelastic devices (OVDs), also known as ophthalmic viscosurgical devices, are a class of clear, gel-like substances used in eye surgery. The name "viscoelastic" comes from their dual properties: the viscosity of a fluid and the elasticity of a solid or gel. These substances are essential tools in modern eye surgery, particularly in cataract and intraocular lens (IOL) implantation procedures. These devices help secure the fragile eye structures, along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.

The overall market for ophthalmic viscoelastic devices is being collectively boosted by the rising prevalence of eye disorders, which is driving surgical demand, along with continuous technological advancements that enhance device performance and safety. Growing awareness and improved access to eye care are expanding patient reach, while the increasing prevalence of diabetes is further adding to the burden of vision-related disorders requiring surgical treatment. Additionally, intensified product development activities by key players are introducing innovative OVD solutions, strengthening market growth globally.

What are the latest Ophthalmic Viscoelastic Devices Market Dynamics and Trends?

The ophthalmic viscoelastic devices (OVDs) market is witnessing significant growth, primarily driven by the increasing prevalence of eye disorders such as cataracts, glaucoma, diabetic retinopathy, and refractive errors. According to DelveInsight's analysis (2024), over 2.25 billion people worldwide suffer from near or distance vision impairment, creating a robust demand for corrective eye surgeries. Since OVDs play a vital role in stabilizing the anterior chamber, protecting the corneal endothelium, and enhancing surgical precision, the expanding global patient pool directly supports higher adoption of these devices.

Cataract surgery remains the leading application area for OVDs. In England alone, more than 516,000 cataract surgeries were performed in 2023 (UK Government, May 2024), highlighting the increasing surgical volume in aging populations. With cataract surgery being the most frequently performed ophthalmic procedure globally, the demand for OVDs is set to grow in tandem, particularly in developed markets with advanced healthcare infrastructure and supportive reimbursement frameworks.

Diabetic retinopathy (DR) is another major contributor, as it is among the most common diabetes-related eye complications, often requiring surgical interventions such as vitrectomy or combined cataract procedures. DelveInsight's estimates (2024) indicate that more than 100 million adults worldwide were living with DR, with nearly 29 million cases of vision-threatening DR (VTDR). These surgical interventions heavily depend on OVDs to maintain anterior chamber depth and ensure safe tissue handling, further expanding their utilization.

Beyond disease burden, technological advancements in ophthalmic surgery are accelerating OVD demand. The adoption of femtosecond laser-assisted cataract surgery, minimally invasive glaucoma surgeries (MIGS), and premium intraocular lenses (IOLs) necessitates the use of high-quality viscoelastics for precision and safety. Moreover, the increasing availability of combination OVDs (dispersive + cohesive properties) is enhancing surgical outcomes and broadening their clinical applications.

Additionally, demographic shifts such as the rapidly aging global population, rising diabetes prevalence, and improved access to advanced ophthalmic care in emerging markets are expected to further fuel market expansion. Favorable government initiatives aimed at reducing avoidable blindness and growing investments in eye-care infrastructure also add to the momentum.

Taken together, the convergence of a growing patient pool, rising surgical volumes, increasing diabetes-related complications, and ongoing technological advancements is expected to significantly propel the ophthalmic viscoelastic devices market over the forecast period.

However, the ophthalmic viscoelastic devices (OVDs) market faces significant challenges, primarily driven by the high cost and complex reimbursement landscape, which can hinder adoption, particularly in budget-constrained healthcare systems. The development of new OVDs is also constrained by stringent regulatory hurdles and lengthy approval processes, which slow down innovation. A key operational challenge is the lack of awareness and specialized training among healthcare professionals, limiting the effective use of these devices. Furthermore, there is a constant risk of post-operative complications, such as increased intraocular pressure, if the OVDs are not used or removed correctly. The market also contends with intense competition from numerous players, as well as the potential for displacement by alternative surgical techniques that may reduce the need for OVDs. These factors, alongside raw material price volatility, collectively create notable restraints and complexities for the OVD market.

Ophthalmic Viscoelastic Devices Market Segment Analysis

Ophthalmic Viscoelastic Devices Market by Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, and Visco-Adaptive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, and Others), End-User (Hospitals, Ophthalmology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Ophthalmic Viscoelastic Devices Market Regional Analysis

North America Ophthalmic Viscoelastic Devices Market Trends

North America is projected to dominate the global ophthalmic viscoelastic devices (OVD) market in 2024, capturing nearly 41% of the total share. This leadership is underpinned by the high prevalence of cataracts and glaucoma, coupled with a rapidly aging population that fuels the rising number of ophthalmic surgical procedures. The region's advanced healthcare infrastructure, strong network of skilled ophthalmic surgeons, and supportive reimbursement frameworks further promote the adoption of premium surgical technologies, cementing its stronghold in the global market.

According to DelveInsight's analysis (2024), in the United States alone, over 25.5 million people were affected by cataracts, while approximately 9.7 million were living with diabetic retinopathy (DR), a leading diabetes-related cause of vision impairment. Both cataracts and DR frequently require surgical interventions such as cataract extraction and vitrectomy, in which OVDs are indispensable for maintaining anterior chamber stability, protecting the corneal endothelium, and ensuring accurate intraocular lens (IOL) implantation. With the continued rise in diabetes prevalence and age-related ocular disorders, the surgical patient pool in North America is set to expand significantly, driving sustained demand for OVDs.

Technological innovation is another key growth accelerator in the region. Next-generation OVDs feature optimized viscosity profiles, dual-action (cohesive-dispersive) properties, and prefilled delivery systems that improve surgical efficiency, safety, and precision. For example, Alcon's DUOVISC(R) Viscoelastic System, which combines PROVISC(R) (cohesive) with VISCOAT(R) (dispersive), provides surgeons with both mechanical support and endothelial protection during cataract procedures. Similarly, Bausch + Lomb's StableVisc(TM) and TotalVisc(TM) systems reflect the ongoing trend toward dual-action OVDs that enhance tissue protection and surgical outcomes. Such innovations not only reduce complications and procedure time but also expand OVD applications to a broader range of surgeries, including glaucoma management and diabetic eye complications.

Additionally, North America's OVD market is strengthened by the presence of leading global players such as Alcon, Bausch + Lomb, and Johnson & Johnson Vision, alongside frequent FDA approvals and product launches that accelerate adoption. The region also leads in the early integration of advanced ophthalmic technologies, including femtosecond laser-assisted cataract surgery, minimally invasive glaucoma surgeries (MIGS), and premium IOL implantation, all of which rely heavily on viscoelastic devices for optimal outcomes.

Taken together, the combination of a large and expanding patient pool, rising surgical volumes, robust healthcare infrastructure, favorable reimbursement, and ongoing product innovation is expected to fuel substantial and sustained growth of the North American OVD market over the forecast period, reinforcing its position as the global leader.

Europe Ophthalmic Viscoelastic Devices Market Trends

Europe is driving the growth of the ophthalmic viscoelastic devices (OVD) market through a combination of factors, including a high prevalence of eye disorders, well-established healthcare infrastructure, and increasing access to advanced surgical procedures. The region has a significant aging population, which contributes to a rising incidence of cataracts and other vision-impairing conditions, thereby increasing the demand for OVDs in surgeries. Additionally, European countries have strong ophthalmic research and development activities, fostering the introduction of innovative viscoelastic products with improved safety and efficacy. Government initiatives, favorable reimbursement policies, and growing awareness about eye health further support the adoption of OVDs across hospitals and specialized eye care centers. The presence of leading market players and continuous technological advancements in OVD formulations also reinforce Europe's position as a key contributor to the overall growth of the global ophthalmic viscoelastic devices market.

Asia-Pacific Ophthalmic Viscoelastic Devices Market Trends

The Asia-Pacific region is emerging as a major growth driver of the ophthalmic viscoelastic devices (OVD) market due to a rapidly increasing patient pool with vision disorders, expanding healthcare infrastructure, and rising adoption of advanced ophthalmic surgeries. Countries such as China, India, and Japan are witnessing a growing prevalence of cataracts, glaucoma, and diabetic retinopathy, driven by aging populations and increasing rates of diabetes. Improved access to specialized eye care, government initiatives promoting eye health, and the expansion of hospitals and surgical centers are facilitating higher OVD utilization. Additionally, growing awareness among patients and healthcare professionals about the benefits of viscoelastic devices is boosting adoption in both urban and semi-urban regions. The combination of high unmet medical needs, increasing surgical volumes, and expanding healthcare investments makes the Asia-Pacific region a significant contributor to the global OVD market growth.

Who are the major players in the ophthalmic viscoelastic devices market?

The following are the leading companies in the ophthalmic viscoelastic devices market. These companies collectively hold the largest market share and dictate industry trends.

• B. Braun SE
• BestMedical
• MINZE HEALTH
• Santron Medtronic
• Potent Medical
• Laborie
• MEDKONSULT medical technology s.r.o.
• The Prometheus Group(R)
• HCItalia srl
• DeltaMed
• MEDICA S.P.A
• Aymed Medical Technology
• EV.SERVICE ITALIA
• tic Medizintechnik GmbH & Co. KG
• Creo Medical Ltd.
• Stericom Ltd.
• Amecath Medical Technologies
• Cook
• Well Lead Medical Co., Ltd.
• Others

How is the competitive landscape shaping the ophthalmic viscoelastic devices market?

The competitive landscape of the ophthalmic viscoelastic devices (OVD) market is highly consolidated, with a few major global players, notably Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec, holding a significant portion of the market share. This high market concentration is driven by the considerable investment required for research and development, regulatory approval, and building a strong reputation for product safety and efficacy. These market leaders leverage their extensive portfolios to offer a full range of OVD types (cohesive, dispersive, and viscoadaptive), often bundling them with other surgical equipment to secure contracts with hospitals and clinics. However, despite the dominance of these multinational corporations, the market also features several smaller, specialized companies and a growing presence of regional players, especially in the Asia-Pacific region. This dynamic environment encourages continuous innovation, with companies focusing on developing next-generation OVDs that improve surgical outcomes, are easier to remove, and address specific surgical needs, thereby shaping the market's evolution and forcing competitors to differentiate through technology and quality.

Recent Developmental Activities in the Ophthalmic Viscoelastic Devices Market

• In February 2025, the FDA granted clearance for the VIA360(TM) surgical system, designed to deliver controlled doses of viscoelastic fluid during ophthalmic surgeries, including trabeculotomy procedures.
• In April 2023, Bausch + Lomb launched StableVisc(TM), a cohesive ophthalmic viscosurgical device, and the TotalVisc(TM) Viscoelastic System in the U.S., offering surgeons advanced dual-action protection and enhanced safety during cataract surgery.

Ophthalmic Viscoelastic Devices Market Segmentation

• Ophthalmic Viscoelastic Devices Type Exposure
• Cohesive Ophthalmic Viscoelastic
• Dispersive Ophthalmic Viscoelastic
• Combination Ophthalmic Viscoelastic
• Visco-Adaptive Ophthalmic Viscoelastic
• Ophthalmic Viscoelastic Devices Application Exposure
• Cataract Surgery
• Glaucoma Surgery
• Corneal Transplantation
• Vitreoretinal Surgery
• Others
• Ophthalmic Viscoelastic Devices End-Users Exposure
• Hospitals
• Ophthalmology Clinics
• Others
• Ophthalmic Viscoelastic Devices Geography Exposure
• North America Ophthalmic Viscoelastic Devices Market
• United States Ophthalmic Viscoelastic Devices Market
• Canada Ophthalmic Viscoelastic Devices Market
• Mexico Ophthalmic Viscoelastic Devices Market
• Europe Ophthalmic Viscoelastic Devices Market
• United Kingdom Ophthalmic Viscoelastic Devices Market
• Germany Ophthalmic Viscoelastic Devices Market
• France Ophthalmic Viscoelastic Devices Market
• Italy Ophthalmic Viscoelastic Devices Market
• Spain Ophthalmic Viscoelastic Devices Market
• Rest of Europe Ophthalmic Viscoelastic Devices Market
• Asia-Pacific Ophthalmic Viscoelastic Devices Market
• China Ophthalmic Viscoelastic Devices Market
• Japan Ophthalmic Viscoelastic Devices Market
• India Ophthalmic Viscoelastic Devices Market
• Australia Ophthalmic Viscoelastic Devices Market
• South Korea Ophthalmic Viscoelastic Devices Market
• Rest of Asia-Pacific Ophthalmic Viscoelastic Devices Market
• Rest of the World Ophthalmic Viscoelastic Devices Market
• South America Ophthalmic Viscoelastic Devices Market
• Middle East Ophthalmic Viscoelastic Devices Market
• Africa Ophthalmic Viscoelastic Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are increasingly influencing the ophthalmic viscoelastic devices (OVD) market by enhancing surgical precision, safety, and patient outcomes. Advanced AI algorithms integrated with ophthalmic imaging and diagnostic systems can analyze individual patient anatomy and ocular conditions to recommend the most appropriate type of OVD, whether cohesive, dispersive, combination, or visco-adaptive, for specific procedures. In AI-assisted or robotic-assisted cataract and anterior segment surgeries, AI can optimize parameters such as injection rate, volume, and placement of the OVD, ensuring stable anterior chamber maintenance and reducing the risk of complications. Additionally, AI-driven predictive models help surgeons anticipate post-operative outcomes, guiding the selection of OVDs and surgical strategies tailored to each patient. On the product development side, AI and machine learning are used to simulate viscoelastic properties and tissue interactions, accelerating the design of next-generation OVDs with improved biocompatibility, viscosity, and dual-action performance. Collectively, these AI-powered innovations are not only improving surgical efficiency and patient safety but also expanding the adoption and evolution of ophthalmic viscoelastic devices in modern ophthalmology.

U.S. Tariff Impact Analysis on Ophthalmic Viscoelastic Devices Market:

The U.S. tariff landscape has introduced significant challenges to the ophthalmic viscoelastic devices (OVD) market, impacting both manufacturers and healthcare providers. In 2025, the U.S. imposed a universal 5% baseline tariff on most imported medical devices and components, including critical raw materials like sodium hyaluronate, essential for OVD production.

These elevated tariffs have led to increased production costs, which are often passed on to healthcare providers and patients, potentially affecting the affordability and accessibility of eye surgeries. The optical industry has expressed concerns over these trade policies, highlighting the essential nature of vision care products and the financial strain on businesses, particularly smaller enterprises and independent retailers.

In response to these challenges, companies are exploring alternative sourcing strategies, such as diversifying supply chains and increasing domestic production, to mitigate the impact of tariffs. However, the uncertainty surrounding ongoing trade negotiations and potential future tariff adjustments continues to pose risks to the stability and growth of the OVD market in the U.S.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the ophthalmic viscoelastic devices market report study

• Market size analysis for the current ophthalmic viscoelastic devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the ophthalmic viscoelastic devices market.
• Various opportunities available for the other competitors in the ophthalmic viscoelastic devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current ophthalmic viscoelastic devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the ophthalmic viscoelastic devices market growth in the future?

Frequently Asked Questions for the Ophthalmic Viscoelastic Devices Market

1. What is the growth rate of the ophthalmic viscoelastic devices market?

• The ophthalmic viscoelastic devices market is estimated to grow at a CAGR of 5.21% during the forecast period from 2025 to 2032.

2. What is the market for ophthalmic viscoelastic devices?

• The ophthalmic viscoelastic devices market was valued at USD 459.30 million in 2024, and is expected to reach USD 684.97 million by 2032.

3. Which region has the highest share in the ophthalmic viscoelastic devices market?

• North America is expected to dominate the overall ophthalmic viscoelastic devices market due to the high prevalence of cataract and glaucoma cases, a rapidly aging population, and strong adoption of advanced ophthalmic surgical procedures. The region benefits from well-established healthcare infrastructure, availability of skilled ophthalmic surgeons, and favorable reimbursement policies. Additionally, the presence of leading market players and continuous product innovations further strengthens North America's dominant position in the global market.

4. What are the drivers for the ophthalmic viscoelastic devices market?

• The overall market for ophthalmic viscoelastic devices is being collectively boosted by the rising prevalence of eye disorders, which is driving surgical demand, along with continuous technological advancements that enhance device performance and safety. Growing awareness and improved access to eye care are expanding patient reach, while the increasing prevalence of diabetes is further adding to the burden of vision-related disorders requiring surgical treatment. Additionally, intensified product development activities by key players are introducing innovative OVD solutions, strengthening market growth globally.

5. Who are the key players operating in the ophthalmic viscoelastic devices market?

• Some of the key market players operating in the ophthalmic viscoelastic devices market include B. Braun SE, BestMedical, MINZE HEALTH, Santron, Medtronic, Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group(R), HCItalia srl, DeltaMed, MEDICA S.P.A., Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd., Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd., and others.

Table of Contents

1. Ophthalmic Viscoelastic Devices Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Ophthalmic Viscoelastic Devices Market Executive Summary

• 2.1 Market at Glance

3. Ophthalmic Viscoelastic Devices Market Key Factors Analysis

• 3.1 Ophthalmic Viscoelastic Devices Market Drivers
  • 3.1.1 Rising prevalence of eye disorders
  • 3.1.2 Rising awareness and access to eye care
  • 3.1.3 Increase in technological advancement
  • 3.1.4 Increase in product development activities among the key market players
• 3.2 Ophthalmic Viscoelastic Devices Market Restraints and Challenges
  • 3.2.1 Risk associated with OVD removal
  • 3.2.2 High Cost and Reimbursement Challenges
  • 3.2.3 Regulatory Hurdles and Stringent Approval Processes
• 3.3 Ophthalmic Viscoelastic Devices Market Opportunity
  • 3.3.1 Formulations of new OVDs with improved properties, such as enhanced viscosity

4. Impact Analysis

• 4.1 AI-Powered Innovations and Applications
• 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

• 5.1 The United States
• 5.2 Europe
• 5.3 Japan
• 5.4 China

6. Ophthalmic Viscoelastic Devices Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Ophthalmic Viscoelastic Devices Market Assessment

• 7.1 By Type
  • 7.1.1 Cohesive Ophthalmic Viscoelastic
  • 7.1.2 Dispersive Ophthalmic Viscoelastic
  • 7.1.3 Combination Ophthalmic Viscoelastic
  • 7.1.4 Visco-Adaptive Ophthalmic Viscoelastic
• 7.2 By Application
  • 7.2.1 Cataract Surgery
  • 7.2.2 Glaucoma Surgery
  • 7.2.3 Corneal Transplantation
  • 7.2.4 Vitreoretinal Surgery
  • 7.2.5 Others
• 7.3 By End-Users
  • 7.3.1 Hospitals
  • 7.3.2 Ophthalmology Clinics
  • 7.3.3 Others
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 United States Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.1.2 Canada Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.1.3 Mexico Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
  • 7.4.2 Europe
    • 7.4.2.1 France Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2.2 Germany Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2.3 United Kingdom Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2.4 Italy Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2.5 Spain Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2.6 Rest of Europe Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 China Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3.2 Japan Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3.3 India Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3.4 Australia Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3.5 South Korea Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3.6 Rest of Asia-Pacific Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 Middle East Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.4.2 Africa Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.4.3 South America Ophthalmic Viscoelastic Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Ophthalmic Viscoelastic Devices Market Company and Product Profiles

• 10.1 B. Braun SE
  • 10.1.1 Company Overview
  • 10.1.2 Company Snapshot
  • 10.1.3 Financial Overview
  • 10.1.4 Product Listing
  • 10.1.5 Entropy
• 10.2 BestMedical
  • 10.2.1 Company Overview
  • 10.2.2 Company Snapshot
  • 10.2.3 Financial Overview
  • 10.2.4 Product Listing
  • 10.2.5 Entropy
• 10.3 MINZE HEALTH
  • 10.3.1 Company Overview
  • 10.3.2 Company Snapshot
  • 10.3.3 Financial Overview
  • 10.3.4 Product Listing
  • 10.3.5 Entropy
• 10.4 Santron
  • 10.4.1 Company Overview
  • 10.4.2 Company Snapshot
  • 10.4.3 Financial Overview
  • 10.4.4 Product Listing
  • 10.4.5 Entropy
• 10.5 Medtronic
  • 10.5.1 Company Overview
  • 10.5.2 Company Snapshot
  • 10.5.3 Financial Overview
  • 10.5.4 Product Listing
  • 10.5.5 Entropy
• 10.6 Potent Medical
  • 10.6.1 Company Overview
  • 10.6.2 Company Snapshot
  • 10.6.3 Financial Overview
  • 10.6.4 Product Listing
  • 10.6.5 Entropy
• 10.7 Laborie
  • 10.7.1 Company Overview
  • 10.7.2 Company Snapshot
  • 10.7.3 Financial Overview
  • 10.7.4 Product Listing
  • 10.7.5 Entropy
• 10.8 MEDKONSULT medical technology s.r.o.
  • 10.8.1 Company Overview
  • 10.8.2 Company Snapshot
  • 10.8.3 Financial Overview
  • 10.8.4 Product Listing
  • 10.8.5 Entropy
• 10.9 The Prometheus Group(R)
  • 10.9.1 Company Overview
  • 10.9.2 Company Snapshot
  • 10.9.3 Financial Overview
  • 10.9.4 Product Listing
  • 10.9.5 Entropy
• 10.10 HCItalia srl
  • 10.10.1 Company Overview
  • 10.10.2 Company Snapshot
  • 10.10.3 Financial Overview
  • 10.10.4 Product Listing
  • 10.10.5 Entropy
• 10.11 DeltaMed
  • 10.11.1 Company Overview
  • 10.11.2 Company Snapshot
  • 10.11.3 Financial Overview
  • 10.11.4 Product Listing
  • 10.11.5 Entropy
• 10.12 MEDICA S.P.A
  • 10.12.1 Company Overview
  • 10.12.2 Company Snapshot
  • 10.12.3 Financial Overview
  • 10.12.4 Product Listing
  • 10.12.5 Entropy
• 10.13 Aymed Medical Technology
  • 10.13.1 Company Overview
  • 10.13.2 Company Snapshot
  • 10.13.3 Financial Overview
  • 10.13.4 Product Listing
  • 10.13.5 Entropy
• 10.14 EV.SERVICE ITALIA
  • 10.14.1 Company Overview
  • 10.14.2 Company Snapshot
  • 10.14.3 Financial Overview
  • 10.14.4 Product Listing
  • 10.14.5 Entropy
• 10.15 tic Medizintechnik GmbH & Co. KG
  • 10.15.1 Company Overview
  • 10.15.2 Company Snapshot
  • 10.15.3 Financial Overview
  • 10.15.4 Product Listing
  • 10.15.5 Entropy
• 10.16 Creo Medical Ltd.
  • 10.16.1 Company Overview
  • 10.16.2 Company Snapshot
  • 10.16.3 Financial Overview
  • 10.16.4 Product Listing
  • 10.16.5 Entropy
• 10.17 Stericom Ltd.
  • 10.17.1 Company Overview
  • 10.17.2 Company Snapshot
  • 10.17.3 Financial Overview
  • 10.17.4 Product Listing
  • 10.17.5 Entropy
• 10.18 Amecath Medical Technologies
  • 10.18.1 Company Overview
  • 10.18.2 Company Snapshot
  • 10.18.3 Financial Overview
  • 10.18.4 Product Listing
  • 10.18.5 Entropy
• 10.19 Cook
  • 10.19.1 Company Overview
  • 10.19.2 Company Snapshot
  • 10.19.3 Financial Overview
  • 10.19.4 Product Listing
  • 10.19.5 Entropy
• 10.20 Well Lead Medical Co., Ltd.
  • 10.20.1 Company Overview
  • 10.20.2 Company Snapshot
  • 10.20.3 Financial Overview
  • 10.20.4 Product Listing
  • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us